Pre miRNA

[{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3f16c820301400b337c6/5b6b3ef7e0461e1400300a47.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3f16c820301400b337c6/5b6b3ef7e0461e1400300a47.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3f16c820301400b337c5/5b6b3ef7e0461e1400300a47.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3f16c820301400b337c5/5b6b3ef7e0461e1400300a47.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3f16c820301400b337c4/5b6b3ef7e0461e1400300a47.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3f16c820301400b337c4/5b6b3ef7e0461e1400300a47.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3f16c820301400b337c3/5b6b3ef7e0461e1400300a47.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3f16c820301400b337c3/5b6b3ef7e0461e1400300a47.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3f16c820301400b337c2/5b6b3ef7e0461e1400300a47.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3f16c820301400b337c2/5b6b3ef7e0461e1400300a47.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3f16c820301400b337c1/5b6b3ef7e0461e1400300a47.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3f16c820301400b337c1/5b6b3ef7e0461e1400300a47.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3f16c820301400b337c0/5b6b3ef7e0461e1400300a47.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3f16c820301400b337c0/5b6b3ef7e0461e1400300a47.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3f16c820301400b337bf/5b6b3ef7e0461e1400300a47.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3f16c820301400b337bf/5b6b3ef7e0461e1400300a47.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3f16c820301400b337be/5b6b3ef7e0461e1400300a47.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3f16c820301400b337be/5b6b3ef7e0461e1400300a47.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3f16c820301400b337bd/5b6b3ef7e0461e1400300a47.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3f16c820301400b337bd/5b6b3ef7e0461e1400300a47.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3f16c820301400b337bc/5b6b3ef7e0461e1400300a47.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3f16c820301400b337bc/5b6b3ef7e0461e1400300a47.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3f16c820301400b337bb/5b6b3ef7e0461e1400300a47.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3f16c820301400b337bb/5b6b3ef7e0461e1400300a47.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5b6b3f16c820301400b337ba/5b6b3ef7e0461e1400300a47.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5b6b3f16c820301400b337ba/5b6b3ef7e0461e1400300a47.png"}]